Loading stock data…
Haemonetics Corporation (HAE)
$102.84-0.08 (-0.08%)
Market ClosedLast close Sep 8
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Haemonetics Corporation in the Healthcare sector is trading at $102.84 with a market capitalization of $3.0B. Wall Street consensus targets $108.40 (10 analysts), implying a +5.4% move over the next 12 months. The stock is currently near its 52-week high of $109.57, remaining 41.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $346.35M↑ | $338.97M↑ | $327.31M↑ | $321.39M↓ | $330.60M |
| Gross Profit | $198.21M↓ | $202.39M↑ | $194.74M↑ | $192.24M↓ | $193.05M |
| Operating Income | $52.34M↓ | $68.11M↑ | $67.08M↑ | $53.87M↑ | $50.70M |
| Net Income | -$20.15M↓ | $44.74M↑ | $38.68M↑ | $34.03M↓ | $57.98M |
Peer Comparison
JNJUNHPFE
Fundamentals
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting sof...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.99B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
32.14
Beta
Defensive asset. Lower volatility than the S&P 500.
0.53
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.22%
Volume
Today's trading volume
581,178
Recent News
GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC vs. HAE: Which Stock Is the Better Value Option?
2 Momentum Stocks with Exciting Potential and 1 We Avoid
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Haemonetics (NYSE:HAE) and its peers.
1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Sector Update: Healthcare Stocks Climb Late Afternoon
Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index and the State S